Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1075966 10.3389/fphar.2022.1075966 Pharmacology Correction Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system Guo et al. 10.3389/fphar.2022.1075966 Guo Haoning 1 Wang Bin 2 Yuan Shuying 1 Wu Silin 1 Liu Jing 3 * He Miaoquan 1 * Wang Jisheng 1 * 1 Division of Psychopharmacology, Department of Pharmacy, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China 2 Clinical Experimental Center, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-Sen University, Jiangmen, China 3 Department of Pathology, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Jing Liu, ljing_syy@163.com; Miaoquan He, hmiaoquan_syy@163.com; Jisheng Wang, wjisheng_syy@163.com

This article was submitted to Pharmacoepidemiology, a section of the journal Frontiers in Pharmacology

 09 11 2022 2022 13 1075966 21 10 2022 24 10 2022 Copyright © 2022 Guo, Wang, Yuan, Wu, Liu, He and Wang. 2022 Guo, Wang, Yuan, Wu, Liu, He and Wang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system by Guo H, Wang B, Yuan S, Wu S, Liu J, He M and Wang J (2022). Front. Pharmacol. 13:849758. doi: 10.3389/fphar.2022.849758 esketamine pharmacovigilance neurological adverse events signal FAERS disproportionality analysis

In the original article, there was an error in affiliation 1. Instead of “Division of Psychopharmacology, Department of Pharmacy, The Third People’s Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China”, it should be “Division of Psychopharmacology, Department of Pharmacy, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China”. In the published article, there was an error in affiliation 3. Instead of “Department of Pathology, The Third People’s Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China”, it should be “Department of Pathology, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.